Sign inJoin waitlistJoin the waitlist

Nathaniel Treister

Clinical Director, Oral Medicine and Oral Oncology, Dana-Farber Brigham Cancer Center · Mass General Brigham

Credentials: · · ·

History

Oral Medicine and Oral Oncology · Mass General Brigham
Present
Case Western Reserve University
Present

Internal Medicine
Brigham and Women's Hospital
2004–2005
General Surgery
Brigham and Women's Hospital
2000–2005
University of Pennsylvania School of Dental Medicine
Perelman School of Medicine at the University of Pennsylvania
1996–2000

Research

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group…
Biology of Blood and Marrow Transplantation · 2015 · 2,533 citations
Interleukin-2 and regulatory T cells in graft-versus-host disease
New England Journal of Medicine · 2011 · 929 citations
Rituximab for steroid-refractory chronic graft-versus-host disease
Blood · 2006 · 347 citations

Sook-Bin Woo
52 papers
AV
Alessandro Villa
25 papers
Corey Cutler
24 papers
SS
Stephen Sonis
20 papers
Michael Brennan
17 papers
Lauren Patton
16 papers
Thomas Sollecito
16 papers
Herve Sroussi
15 papers
Stephanie Lee
15 papers
Robert Soiffer
13 papers
Alexander Lin
12 papers
BS
Brian Schmidt
11 papers

Grants

Long Term Oral Health Outcomes in the Chronic GVHD Consortium
National Institute of Dental and Craniofacial Research · R01
Contact PI · $3.7M · Brigham and Women's Hospital
2019–2026
Extraorally Delivered Lo Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation
National Institute of Dental and Craniofacial Research · R34
Contact PI · $322.1K · Brigham and Women's Hospital
2016–2018

Clinical trials

Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation
Principal investigator · Recruiting
Dana-Farber Cancer Institute
2022–2026
An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease
Principal investigator · Terminated · Phase 2
Dana-Farber Cancer Institute
2014–2016
Feasibility Study of Low Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Transplants Patients
Principal investigator · Completed
Dana-Farber Cancer Institute
2014–2016
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
Principal investigator · Completed · Phase 3
Children's Oncology Group
2011–2015